Avanos Medical (NYSE:AVNS - Get Free Report) is projected to post its quarterly earnings results before the market opens on Tuesday, February 18th. Analysts expect Avanos Medical to post earnings of $0.40 per share and revenue of $177.23 million for the quarter.
Avanos Medical Price Performance
AVNS traded down $0.08 during trading on Friday, reaching $16.55. 279,290 shares of the company were exchanged, compared to its average volume of 558,283. The company's 50-day moving average is $16.49 and its two-hundred day moving average is $20.14. The company has a market cap of $760.64 million, a price-to-earnings ratio of 48.68 and a beta of 0.98. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. Avanos Medical has a 12-month low of $14.98 and a 12-month high of $25.36.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered Avanos Medical from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd.
Read Our Latest Report on AVNS
Avanos Medical Company Profile
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
